# FDA Inspection 1094893 - Pharbil Pharma Gmbh - May 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/pharbil-pharma-gmbh/1095cbf5-98ba-4370-8fc2-4ffd196e8a66
Source feed: FDA_Inspections

> FDA Inspection 1094893 for Pharbil Pharma Gmbh on May 22, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094893
- Company Name: Pharbil Pharma Gmbh
- Inspection Date: 2019-05-22
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1287034 - 2024-06-18](https://www.keypedia.com/records/fda_inspections/pharbil-pharma-gmbh/cbc860ac-09b3-4f2f-a660-e2fcefc82027)
- [FDA Inspection 893332 - 2014-08-29](https://www.keypedia.com/records/fda_inspections/pharbil-pharma-gmbh/d028d88f-d163-4079-abae-439411f99582)

Company: https://www.keypedia.com/companies/pharbil-pharma-gmbh/b9e8dd85-63cd-4366-869f-ab086c306910

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c